Your browser doesn't support javascript.
loading
The effect of methotrexate on tumour necrosis factor concentrations in etanercept-treated rheumatoid arthritis patients.
Berkhout, Lea C; l'Ami, Merel J; Krieckaert, Charlotte L M; Vogelzang, Erik H; Kos, Dorien; Nurmohamed, Michael T; Wolbink, Gerrit J; Rispens, Theo.
Afiliação
  • Berkhout LC; Department of Immunopathology, Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, Academic Medical Centre, University of Amsterdam.
  • l'Ami MJ; Amsterdam Rheumatology and immunology Center | Reade.
  • Krieckaert CLM; Amsterdam Rheumatology and immunology Center | Reade.
  • Vogelzang EH; Amsterdam Rheumatology and immunology Center | Reade.
  • Kos D; Department of Immunopathology, Sanquin Research, and Landsteiner Laboratory, Amsterdam UMC, Academic Medical Centre, University of Amsterdam.
  • Nurmohamed MT; Sanquin Reagents B.V.
  • Wolbink GJ; Amsterdam Rheumatology and immunology Center | Reade.
  • Rispens T; Amsterdam Rheumatology and Immunology Center | Amsterdam UMC, VU University Medical Center, Amsterdam, The Netherlands.
Rheumatology (Oxford) ; 59(7): 1703-1708, 2020 07 01.
Article em En | MEDLINE | ID: mdl-31691828

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Metotrexato / Fator de Necrose Tumoral alfa / Antirreumáticos / Etanercepte Limite: Adult / Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Artrite Reumatoide / Metotrexato / Fator de Necrose Tumoral alfa / Antirreumáticos / Etanercepte Limite: Adult / Humans Idioma: En Revista: Rheumatology (Oxford) Assunto da revista: REUMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article